The Premier Audio Journal
by the American College of Cardiology

A proud part of the American College of Cardiology’s distinguished educational portfolio, ACCEL is the premier cardiovascular audio journal, carefully and intuitively designed to help you stay current and meet all your learning needs.

This audio journal delivers short, CME-certified interviews, revealing insights beyond the published data that only conversations between experts could uncover. These vital updates from key cardiology conferences and recently published authors are all available whenever and wherever you choose.

ACCEL Audio Journal Logo from the American College of Cardiology




Explore ACCEL

Listen to interviews on breaking research in Cardiology

From JACC: Mortality Benefit of Rivaroxaban Plus Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease
Deepak Bhatt, MD, FACC
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Interviewer: Spencer B. King III, MD, MACC
Professor of Medicine Emeritus, Emory University School of Medicine, Atlanta, GA

Correspondent: Arjun Majithia, MD
Interventional Cardiology, Lahey Hospital and Medical Center, Burlington, MA

The combination of rivaroxaban (2.5 mg twice daily) and aspirin (100 mg/day) reduces major adverse cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease, compared with aspirin (100 mg/day) alone.

From JACC: Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial
Charles Herzog, MD
Professor of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, MN

Interviewer: Christopher M. Kramer, MD, FACC Chief, Cardiovascular Division, University of Virginia Health System, Charlottesville, VA

Kidney transplantation candidates with a positive stress test (suggestive of blockages in the arteries of the heart) who are treated with optimal medical treatment alone may do equally well as patients treated with optimal medical treatment and stenting or bypass surgery.

Choose the Membership tailor-made for you

Fellows in
Training

Four or more brand new ACCEL interviews, discussions or debates each week.


Starting from:
FREE

Cardiovascular
Team

Four or more brand new ACCEL interviews, discussions or debates each week.


Starting from:
$199

Silver
Membership

Four or more brand new ACCEL interviews, discussions or debates each week.


Starting from:
$399

Gold
Membership

Four or more brand new ACCEL interviews, discussions or debates each week, plus access to 600+ interviews from the past 3 years.

Starting from:
$599

Platinum
Membership

Four or more brand new ACCEL interviews, discussions or debates each week, plus access to every AudioDigest lecture, across every specialty.

Starting from:
$1,499


Subscribe

ACCEL Lite Podcast 

ACCEL Lite Podcast

Listen to interesting interviews, news and more!



Stay Up-to-date with ACCEL Audio Journal


ACCEL provides direct access to the researchers who share backstories and perspective that is unlike any other product. It includes actionable content that’s highly relevant to not only physicians, but today’s comprehensive cardiovascular care team — and translates directly into improved patient care. You will be able to implement new learnings in real–world practice, access convenient, on-the-go cardiovascular education, and stay up–to–date with the latest and greatest in the ever-expanding field of cardiology.

This engaging content includes new interviews and insider discussions covering current, clinically relevant, evidence-based information, insight, and updates. Each interview qualifies for AMA PRA Category 1 Credits™ and ABIM Part II Maintenance of Certification (MOC) Points (Nov 2016 and newer issues).

The ACCEL app makes it easier than ever to stay up–to–date with the latest cardiology news. Subscribe today.

Welcoming New ACCEL Editor-in-Chief
Alison L. Bailey, MD FACC
ACCEL Editor-in-Chief Alison L. Bailey, MD FACC




View
Your
Offer

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.   Agree